学术搜索
科研智能体
- Research Labs
- AI 阅读
- AI 文库
- AMiner 沉思
- AMiner 亮点
学术资源
- AI2000
- 期刊/会议
- 学者库
- 学术API
- 溯源树
- 数据集
知识沉淀
- 学术空间

订阅小程序

旧版功能

aminer vip

开通会员低至0.73元/天

一次搞定AI科研

立即登录

Gary E. Gallick | AMiner学者主页 | AMiner

Gary E. Gallick

教授

University of Texas MD Anderson Cancer Center

278Papers / 论文

1.4万Citations / 引用

63H-Index

浏览量281

个人简介

Gallick won numerous awards including the John P. McGovern Outstanding Teaching Award in 1991 and the Andrew Sowell-Wade Huggins Professorship in Cancer Research for 2006-2007. In 2012, he received The University of Texas Regents’ Outstanding Teacher Award and the MD Anderson Faculty Achievement Award in Education, and was named a Distinguished Teaching Professor by MD Anderson.

Gallick is credited with developing a bidirectional pattern of investigation in his department, encouraging inquiry to flow from the laboratory to the clinic and back. His research focused on Src kinases as well as prostate cancer bone metastases. His work led to a series of co-clinical studies that shed light on vascular heterogeneity in prostate cancer bone metastases. The methods he developed have increased the understanding of the tumor-associated microenvironment in clinical cancers.

Gallick became a member of the AACR in 1992. He was an editorial board member of Clinical Cancer Research from 2003 to 2019.

教育经历

received bachelor’s degree in microbiology from the University of Michigan
master’s degrees in microbiology from the University of Illinois at Urbana-Champaign
doctoral degrees in microbiology from the University of Illinois at Urbana-Champaign

工作经历

professor at The University of Texas MD Anderson Cancer Center

全面呈现 [Gary E. Gallick] 的学术影响力

深度挖掘高质量成果与权威引用，让优秀看得见

研究兴趣

暂无数据

论文（278）

专利

基金项目

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

1Expression of Concern for JAK2-binding Long Noncoding RNA Promotes Breast Cancer Brain Metastasis.

Shouyu Wang,Ke Liang,Qingsong Hu,Ping Li,Jian Song,Yuedong Yang,Jun Yao, Lingegowda Selanere Mangala,Chunlai Li, Wenhao Yang, Peter K Park,David H Hawke,

2025The Journal of clinical investigation（2025）引用：6

引用

加入学术空间

2Figure S4 from Osteoblast-Secreted Factors Mediate Dormancy of Metastatic Prostate Cancer in the Bone via Activation of the TGFβRIII–p38MAPK–pS249/T252RB Pathway

Li-Yuan Yu-Lee,Guoyu Yu,Yu-Chen Lee,Song-Chang Lin,Jing Pan,Tianhong Pan,Kai-Jie Yu,Bin Liu,Chad J. Creighton,Jaime Rodriguez-Canales,Pamela A. Villalobos,Ignacio I. Wistuba,

<p>Intrabone p38DN tumor growth and cell proliferation.</p>

2023

引用

加入学术空间

3Supplemental Figure S6 from Identification of Bone-Derived Factors Conferring <i>De Novo</i> Therapeutic Resistance in Metastatic Prostate Cancer

Yu-Chen Lee,Song-Chang Lin,Guoyu Yu,Chien-Jui Cheng,Bin Liu,Hsuan-Chen Liu,David H. Hawke,Nila U. Parikh,Andreas Varkaris,Paul Corn,Christopher Logothetis,Robert L. Satcher,

Combination of cabozantinib with PF-562271 delays tumor recurrence after treatments cessation.

2023

引用

加入学术空间

4Supplementary Figure 4 from Epithelial to Mesenchymal Transition Contributes to Drug Resistance in Pancreatic Cancer

Thiruvengadam Arumugam,Vijaya Ramachandran,Keith F. Fournier,Huamin Wang,Lauren Marquis,James L. Abbruzzese,Gary E. Gallick,Craig D. Logsdon,David J. McConkey,Woonyoung Choi

Supplementary Figure 4 from Epithelial to Mesenchymal Transition Contributes to Drug Resistance in Pancreatic Cancer

2023

引用

加入学术空间

5Supplementary Table from Inhibition of Cell Adhesion by a Cadherin-11 Antibody Thwarts Bone Metastasis

Yu-Chen Lee,Mehmet Asim Bilen, Guoyu Yu, Song-Chang Lin,Chih-Fen Huang,Angelica Ortiz,Hyojin Cho,Jian H. Song, Robert L. Satcher,Jian Kuang,Gary E. Gallick, Li-Yuan Yu-Lee,

PDF file, 18K, Oligonucleotide sequences used in this study.

2023

引用

加入学术空间

6Supplementary Figure Legends 1-6, Tables 1-2 from Epithelial to Mesenchymal Transition Contributes to Drug Resistance in Pancreatic Cancer

Thiruvengadam Arumugam,Vijaya Ramachandran,Keith F. Fournier,Huamin Wang,Lauren Marquis,James L. Abbruzzese,Gary E. Gallick,Craig D. Logsdon,David J. McConkey,Woonyoung Choi

Supplementary Figure Legends 1-6, Tables 1-2 from Epithelial to Mesenchymal Transition Contributes to Drug Resistance in Pancreatic Cancer

2023

引用

加入学术空间

7Supplementary Table 3 from Resistance to BRAF Inhibition in BRAF-Mutant Colon Cancer Can Be Overcome with PI3K Inhibition or Demethylating Agents

Muling Mao, Feng Tian,John M. Mariadason,Chun C. Tsao,Robert Lemos,Farshid Dayyani,Y.N. Vashisht Gopal,Zhi-Qin Jiang,Ignacio I. Wistuba,Xi M. Tang,William G. Bornman,Gideon Bollag,

PDF file - 48K, RPPA data for the colon and melanoma cell lines. Values are log-base 2, normalized to both total protein loading per sample and the median protein expression. HT29/WiDr, and Colo201/Colo205 are derived from the same patient under different time courses/conditions, and therefore may be provide limited additional data (Semple TU et al., Cancer Res. 1978 May;38(5):1345-55, Chen TR et al Cancer Genet Cytogenet. 1987 Jul;27(1):125-34). Sensitivity analysis demonstrates no change in the conclusions with the inclusion or exclusion of these isogenic cell lines.

2023

引用

加入学术空间

8Figure S6 from Targeting Src and Tubulin in Mucinous Ovarian Carcinoma

Tao Liu,Wei Hu,Heather J. Dalton, Hyun Jin Choi, Jie Huang,Yu Kang, Sunila Pradeep, Takahito Miyake,Jian H. Song, Yunfei Wen,Chunhua Lu, Chad V. Pecot,

PDF file 190K, Figure S6. (A, B) Glu-tubulin immunofluorescence staining (green) in RMUG-S and RMUG-L cells treated with 100 nM KX-01 for 24 hours and incubated with anti-glu-tubulin antibody followed by Alexa Fluor 488-conjugated anti-rabbit antibody. Nuclei (blue) were stained with DAPI. Left: tubulin stain only; Middle: DAPI nuclear stain; Right: tubulin and DAPI nuclear stain

2023

引用

加入学术空间

9Supplementary Figure 2 from Colorectal Adenoma Stem-like Cell Populations: Associations with Adenoma Characteristics and Metachronous Colorectal Neoplasia

Angela N. Bartley,Nila Parikh,Chiu-Hsieh Hsu,Denise J. Roe,Julie A. Buckmeier,Lynda Corley,Ron A. Phipps,Gary Gallick,Peter Lance,Patricia A. Thompson,Stanley R. Hamilton

PDF file - 20K, Supplemental Figure showing ALDH1 intra-class correlation.

2023

引用

加入学术空间

10Supplemental Figure S5 from Identification of Bone-Derived Factors Conferring <i>De Novo</i> Therapeutic Resistance in Metastatic Prostate Cancer

Yu-Chen Lee,Song-Chang Lin,Guoyu Yu,Chien-Jui Cheng,Bin Liu,Hsuan-Chen Liu,David H. Hawke,Nila U. Parikh,Andreas Varkaris,Paul Corn,Christopher Logothetis,Robert L. Satcher,

<p>Mouse body weights during treatments.</p>

2023

引用

加入学术空间

11Supplementary Table S1 from Src Continues Aging: Current and Future Clinical Directions

Scott Kopetz, Ami N. Shah,Gary E. Gallick

Supplementary Table S1 from Src Continues Aging: Current and Future Clinical Directions

2023

引用

加入学术空间

12Figure S1 from Cabozantinib Reverses Renal Cell Carcinoma–mediated Osteoblast Inhibition in Three-dimensional Coculture in Vitro and Reduces Bone Osteolysis in Vivo

Tianhong Pan,Mariane Martinez,Kelsea M. Hubka,Jian H. Song,Song-Chang Lin,Guoyu Yu,Yu-Chen Lee,Gary E. Gallick,Shi-Ming Tu,Daniel A. Harrington,Mary C. Farach-Carson,Sue-Hwa Lin,

Differentiation of pre-osteoblast MC3T3-E1 cells in 3D hydrogel

2023

引用

加入学术空间

13Supplementary Figure 3 from Epithelial to Mesenchymal Transition Contributes to Drug Resistance in Pancreatic Cancer

Thiruvengadam Arumugam,Vijaya Ramachandran,Keith F. Fournier,Huamin Wang,Lauren Marquis,James L. Abbruzzese,Gary E. Gallick,Craig D. Logsdon,David J. McConkey, Woonyoung Choi

Supplementary Figure 3 from Epithelial to Mesenchymal Transition Contributes to Drug Resistance in Pancreatic Cancer

2023

引用

加入学术空间

14Supplemental Figure S4 from Identification of Bone-Derived Factors Conferring <i>De Novo</i> Therapeutic Resistance in Metastatic Prostate Cancer

Yu-Chen Lee,Song-Chang Lin,Guoyu Yu,Chien-Jui Cheng,Bin Liu,Hsuan-Chen Liu,David H. Hawke,Nila U. Parikh,Andreas Varkaris,Paul Corn,Christopher Logothetis,Robert L. Satcher,

<p>FAK inhibitor defactinib inhibited PC3-mm2 cell survival in vitro.</p>

2023

引用

加入学术空间

15Table S3 from Osteoblast-Secreted Factors Mediate Dormancy of Metastatic Prostate Cancer in the Bone via Activation of the TGFβRIII–p38MAPK–pS249/T252RB Pathway

Li-Yuan Yu-Lee,Guoyu Yu,Yu-Chen Lee,Song-Chang Lin,Jing Pan,Tianhong Pan,Kai-Jie Yu,Bin Liu,Chad J. Creighton,Jaime Rodriguez-Canales,Pamela A. Villalobos,Ignacio I. Wistuba,

<p>Selected factors secreted from Day 30 differentiated osteoblasts.</p>

2023

引用

加入学术空间

16Figure S1 from Osteoblast-Secreted Factors Mediate Dormancy of Metastatic Prostate Cancer in the Bone via Activation of the TGFβRIII–p38MAPK–pS249/T252RB Pathway

Li-Yuan Yu-Lee,Guoyu Yu,Yu-Chen Lee,Song-Chang Lin,Jing Pan,Tianhong Pan,Kai-Jie Yu,Bin Liu,Chad J. Creighton,Jaime Rodriguez-Canales,Pamela A. Villalobos,Ignacio I. Wistuba,

<p>DiO-labeling of C4-2B4 PCa cells.</p>

2023

引用

加入学术空间

17Supplementary Figure 1 from Colorectal Adenoma Stem-like Cell Populations: Associations with Adenoma Characteristics and Metachronous Colorectal Neoplasia

Angela N. Bartley,Nila Parikh,Chiu-Hsieh Hsu,Denise J. Roe,Julie A. Buckmeier,Lynda Corley,Ron A. Phipps,Gary Gallick,Peter Lance,Patricia A. Thompson,Stanley R. Hamilton

PDF file - 636K, Representative images of ALDH1 staining and enumeration by Aperio Genie with color.

2023

引用

加入学术空间

18Supplementary Table 1 from BMP4 Promotes Prostate Tumor Growth in Bone Through Osteogenesis

Yu-Chen Lee,Chien-Jui Cheng, Mehmet A. Bilen,Jing-Fang Lu,Robert L. Satcher, Li-Yuan Yu-Lee,Gary E. Gallick,Sankar N. Maity, Sue-Hwa Lin

Supplementary Table 1 from BMP4 Promotes Prostate Tumor Growth in Bone through Osteogenesis

2023

引用

加入学术空间

19Figure S2 from Cabozantinib Reverses Renal Cell Carcinoma–mediated Osteoblast Inhibition in Three-dimensional Coculture in Vitro and Reduces Bone Osteolysis in Vivo

Tianhong Pan,Mariane Martinez,Kelsea M. Hubka,Jian H. Song,Song-Chang Lin,Guoyu Yu,Yu-Chen Lee,Gary E. Gallick,Shi-Ming Tu,Daniel A. Harrington,Mary C. Farach-Carson,Sue-Hwa Lin,

ALP and OSC gene expression in human Bo-786 RCC cells and PC3 prostate cancer cells

2023

引用

加入学术空间

20Figure S2 from Targeting Src and Tubulin in Mucinous Ovarian Carcinoma

Tao Liu, Wei Hu,Heather J. Dalton, Hyun Jin Choi, Jie Huang,Yu Kang, Sunila Pradeep, Takahito Miyake,Jian H. Song, Yunfei Wen,Chunhua Lu, Chad V. Pecot,

PDF file 196K, Figure S2. Effects of KX-01 and oxaliplatin on cell proliferation (Ki-67; A), angiogenesis (CD31; B), apoptosis (Cleaved caspase-3; C) RMUG-L model. Original magnification 200x . Bars in the graphs correspond sequentially to the labeled columns of images on the left. Data are shown as mean {plus-minus} standard deviation (error bars). *p<0.05, **p<0.01 compared with the control group

2023

引用

加入学术空间

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

Sue-Hwa Lin合作论文数Department of Translational Molecular Pathology, Division of Pathology/Lab Medicine, The University of Texas MD Anderson Cancer Center;Department of Genitourinary Oncology, Division of Medicine, The University of Texas MD Anderson Cancer Center;Graduate School of Biomedical Sciences, The University of Texas Health Science Center at Houston64

Nila U. Parikh

Nila U. Parikh合作论文数54

Lee Yu-Chen

Lee Yu-Chen合作论文数46

Christopher J. Logothetis合作论文数Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center;Department of The David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center46

Guoyu Yu合作论文数Division of Pathology-Lab Medicine Div, Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center41

Song-Chang Lin

Song-Chang Lin合作论文数40

Li-Yuan Yu-Lee

Li-Yuan Yu-Lee合作论文数40

Jian Song

Jian Song合作论文数39

Robert L. Satcher合作论文数Department of Orthopaedic Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center;Ken Kennedy Institute of Information Technology, Rice University;Department of Biomedical Engineering, Northwestern University28

Paul G. Corn

Paul G. Corn合作论文数27

Chien-Jui Cheng合作论文数27

Scott Kopetz合作论文数Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center26

Anil K. Sood合作论文数Department of Gynecologic Oncology and Reproductive Medicine, Division of Surgery, The University of Texas MD Anderson Cancer Center;Graduate School of Biomedical Sciences, The University of Texas Health Science Center25

Varkaris Andreas合作论文数Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center24

Bin Liu

Bin Liu合作论文数23

Farshid Dayyani合作论文数23

Ignacio I. Wistuba合作论文数Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center;Department of Pathology, The University of Texas MD Anderson Cancer Center22

Tianhong Pan

Tianhong Pan合作论文数21

Justin M. Summy

Justin M. Summy合作论文数18

James Abbruzzese合作论文数Division of Medical Oncology, Department of Medicine, Duke University School of Medicine;Duke Cancer Institute18

Jian Kuang

Jian Kuang合作论文数17

David H. Hawke

David H. Hawke合作论文数Department of Molecular Pathology, The University of Texas M. D. Anderson Cancer Center17

John C. Araujo合作论文数Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center16

Gabriel Lopez-Berestein合作论文数Department of Experimental Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center15

Huamin Wang (王华民)合作论文数Department of Pathology, Division of Pathology/Lab Medicine, The University of Texas MD Anderson Cancer Center;MD Anderson UT Health Graduate School of Biomedical Sciences, The University of Texas15

Kai-Jie Yu

Kai-Jie Yu合作论文数14

Zhiqin Jiang

Zhiqin Jiang合作论文数Department of Gastrointestinal Medical Oncology, The University of Texas-MD Anderson Cancer Center14

Michael P. Kim

Michael P. Kim合作论文数13

Jing Pan

Jing Pan合作论文数13

Jose G Trevino合作论文数Department of Surgery, University of Florida College of Medicine13

David McConkey合作论文数Johns Hopkins Greenberg Bladder Cancer Institute;Department of Urology, School of Medicine, Johns Hopkins University13

Pamela Villalobos

Pamela Villalobos合作论文数Dept Translat Mol Pathol, Univ Texas MD Anderson Canc Ctr12

Jaime Rodriguez-Canales合作论文数Daiichi Sankyo12

Hsuan-Chen Liu合作论文数Sino Biological, Inc.12

Chad Creighton合作论文数Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine;Human Genome Sequencing Center, Baylor College of Medicine12

Gordon Mills合作论文数School of Medicine, Oregon Health Sciences University12

Francesc Posas

Francesc Posas合作论文数Departament de Ciències Experimentals i de la Salut, Universitat Pompeu Fabra (UPF),12

Eulalia De Nadal合作论文数Universitat Pompeu Fabra;Institute for Research in Biomedicine12

Sankar Maity合作论文数The University of Texas M.D. Anderson Cancer Center12

Muling Mao

Muling Mao合作论文数11

Bollag Gideon

Bollag Gideon合作论文数11

Michael A. Davies合作论文数Department of Melanoma Medical Oncology, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center11

Craig D. Logsdon

Craig D. Logsdon合作论文数11

William G. Bornmann合作论文数Memorial Sloan-Kettering Cancer Center11

J. Bottsford-Miller

J. Bottsford-Miller合作论文数11

Chun Chui Tsao

Chun Chui Tsao合作论文数10

Robert Lemos合作论文数Dept Expt Therapeut, Univ Texas MD Anderson Canc Ctr10

Menashe Bar-Eli合作论文数10

Serk In Park合作论文数Department of Biochemistry and Molecular Biology, College of Medicine, Korea University10

相似学者

Christopher J. Logothetis

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn